Analystreport

Albany Molecular Research, Inc. (NASDAQ: AMRI) had its "outperform" rating re-affirmed by analysts at William Blair.

ALBANY MOLECULAR RESEARCH  (AMRI) 
Last albany molecular research earnings: 5/9 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: amriglobal.com/about-us/investor-relations